US 8518980
Treatment of Duchenne muscular dystrophy
granted A61KA61K31/343A61K31/404
Quick answer
US patent 8518980 (Treatment of Duchenne muscular dystrophy) held by Summit Corporation Plc expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Summit Corporation Plc
- Grant date
- Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/343, A61K31/404, A61K31/4184, A61K31/4192